India · Delayed Price · Currency is INR Aurobindo Pharma Statistics
Total Valuation
BOM:524804 has a market cap or net worth of INR 605.25 billion. The enterprise value is 605.46 billion.
| Market Cap | 605.25B |
| Enterprise Value | 605.46B |
Important Dates
The next estimated earnings date is Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | Aug 8, 2025 |
Share Statistics
| Current Share Class | 580.80M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.74% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 278.45M |
Valuation Ratios
The trailing PE ratio is 17.85 and the forward PE ratio is 15.54.
| PE Ratio | 17.85 |
| Forward PE | 15.54 |
| PS Ratio | 1.89 |
| PB Ratio | 1.85 |
| P/TBV Ratio | 2.13 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 17.85 |
| EV / Sales | 1.89 |
| EV / EBITDA | 9.13 |
| EV / EBIT | 12.33 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.25 |
| Debt / EBITDA | 1.24 |
| Debt / FCF | n/a |
| Interest Coverage | 11.12 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 7.97% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 12.31M |
| Profits Per Employee | 1.30M |
| Employee Count | 26,015 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:524804 has paid 15.60 billion in taxes.
| Income Tax | 15.60B |
| Effective Tax Rate | 31.51% |
Stock Price Statistics
The stock price has decreased by -28.85% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -28.85% |
| 50-Day Moving Average | 1,129.91 |
| 200-Day Moving Average | 1,190.89 |
| Relative Strength Index (RSI) | 31.04 |
| Average Volume (20 Days) | 33,062 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:524804 had revenue of INR 320.25 billion and earned 33.91 billion in profits. Earnings per share was 58.32.
| Revenue | 320.25B |
| Gross Profit | 188.32B |
| Operating Income | 49.38B |
| Pretax Income | 49.49B |
| Net Income | 33.91B |
| EBITDA | 66.57B |
| EBIT | 49.38B |
| Earnings Per Share (EPS) | 58.32 |
Balance Sheet
The company has 82.36 billion in cash and 82.63 billion in debt, giving a net cash position of -273.70 million.
| Cash & Cash Equivalents | 82.36B |
| Total Debt | 82.63B |
| Net Cash | -273.70M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 326.47B |
| Book Value Per Share | 562.37 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 58.80%, with operating and profit margins of 15.42% and 10.59%.
| Gross Margin | 58.80% |
| Operating Margin | 15.42% |
| Pretax Margin | 15.45% |
| Profit Margin | 10.59% |
| EBITDA Margin | 20.79% |
| EBIT Margin | 15.42% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 4.00, which amounts to a dividend yield of 0.38%.
| Dividend Per Share | 4.00 |
| Dividend Yield | 0.38% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.74% |
| Shareholder Yield | 1.13% |
| Earnings Yield | 5.60% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 20, 2015. It was a forward split with a ratio of 2.
| Last Split Date | Jul 20, 2015 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |